L3 Harris (LHX) appoints Sam Mehta as President and CEO; affirms guidance
Newsquawk Staff ·
L3 Harris (LHX) appoints Sam Mehta as President and CEO; affirms guidance.
What it means
CEO appointments at defence primes of this scale have historically been priced on the successor's pedigree and on whether the transition signals continuity or a strategic reset, with the affirmed guidance here pointing to the former. Guidance reaffirmed on the day of a leadership change is the standard playbook for capping succession risk and has generally limited the initial equity reaction to the gap between the incoming executive's prior mandate and the existing one. The relevant questions are whether the hire is internal or external, what their track record implies for capital allocation priorities (buybacks versus M&A versus program investment), and whether the outgoing chief's departure was telegraphed or abrupt, since unplanned transitions at defence contractors have tended to draw scrutiny of program execution and margin trajectory. Worth watching are any accompanying board or segment leadership changes, commentary around the appointment timing, and whether the reaffirmed guidance survives the next earnings call intact. Defense names with stable government backlogs have historically absorbed leadership changes with less multiple compression than industrials facing cyclical order risk, provided the outlook is held steady.
Sources
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED
Related headlines
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising5 hours ago
- Uber (UBER) puts all 30,000 employees on ChatGPT Work5 hours ago
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP6 hours ago
- Nvidia (NVDA) launches Minerva platform for end-to-end AI factory observability7 hours ago
- Fireblocks denies talks with Visa (V), CoinDesk reports7 hours ago
- Norfolk Southern (NSC) says tightening truck capacity is improving rail competitiveness, supporting truck-to-rail conversions and stronger customer demand7 hours ago
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile8 hours ago
- Procter & Gamble (PG) CFO says 'so far, consumer has held up, we don't know if that's going to continue'8 hours ago
- Meta's (META) 5yr CDS hits an all-time high at 114.5bps8 hours ago
- eBay (EBAY) confirms plans to reduce workforce by 9%; expects Q3 results above guidance 8 hours ago
- Google (GOOGL) is launching an agent compute engine8 hours ago
- AbbVie (ABBV) announces positive topline results from the Phase 3 INTREPID study evaluating the safety and efficacy of lutikizumab in adults and adolescents with moderate to severe hidradenitis suppurativa9 hours ago
- Union Pacific (UNP) says will continue to build cash reserves ahead of the Norfolk Southern (NSC) merger; expects to close merger in second half of F279 hours ago
- P&G (PG) CFO says expect materially higher cost headwinds in Q2 and second half of fiscal 2027 from higher oil prices9 hours ago
- Norfolk Southern (NSC) raises FY26 CAPEX guidance to USD 2.1bln (prev. 1.9bln) and adj. operating expenses to USD 9.0bln (prev. 8.8-8.9bln)9 hours ago